Norman E. Rosenthal is a world-renowned psychiatrist, public speaker, and best-selling author.
Rosenthal was the first to diagnose Seasonal Affective Disorder (SAD) and light therapy to treat it.
A best selling author (Transcendence, The Gift of Adversity and Super Mind), he is also an executive coach and popular public speaker. He is currently Clinical Professor of Psychiatry at Georgetown University School of Medicine and is listed as one of the Best Doctors in America. Dr. Rosenthal has practiced psychiatry for over three decades, treating people with all manner of psychiatric and emotional health issues. He is also a motivational speaker and a personal and professional coach, working with people from all walks of life including CEOs, top athletes, and performing artists.
Rosenthal was born and raised in South Africa and did his medical training at the University of Witwatersrand, where he graduated with high honors. He immigrated to the US and did his psychiatric residency at Columbia in NYC before going to the National Institute of Health in Bethesda, Maryland, where he began his research career in earnest. His first major research contribution was to describe and name Seasonal Affective Disorder (SAD) and to develop light therapy as a treatment for this novel condition. SAD – and its milder variant, the Winter Blues – are now known to affect millions of people worldwide, many of whom have benefited from the light therapy that Dr. Rosenthal pioneered.
Dr. Rosenthal is a highly cited researcher who has written over 200 scholarly articles, and authored or co-authored eight popular books. These include Winter Blues, the New York Times bestseller Transcendence, and the Los Angeles Times bestseller The Gift of Adversity. Rosenthal has conducted numerous clinical trials of medications and alternative treatments, such as Transcendental Meditation for psychiatric disorders, and the treatment of depression with Botox. He and his work have been featured on Good Morning America, The Today Show, NPR and other national media.